270 related articles for article (PubMed ID: 29934414)
1. Phantom menace: novel psychoactive substances and the UK Armed Forces.
Hunter AH; Ayres T; Moreland N; Cox A
J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
[TBL] [Abstract][Full Text] [Related]
2. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
3. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
Schifano F; Papanti GD; Orsolini L; Corkery JM
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
[TBL] [Abstract][Full Text] [Related]
4. A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia.
Anderson C; Morrell C; Marchevsky D
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948854
[TBL] [Abstract][Full Text] [Related]
5. The emergence of new psychoactive substance (NPS) benzodiazepines: A review.
Manchester KR; Lomas EC; Waters L; Dempsey FC; Maskell PD
Drug Test Anal; 2018 Jan; 10(1):37-53. PubMed ID: 28471096
[TBL] [Abstract][Full Text] [Related]
6. Managing misuse of novel psychoactive substances.
Solomon D; Grewal P; Taylor C; Solomon B
Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370
[TBL] [Abstract][Full Text] [Related]
7. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
[TBL] [Abstract][Full Text] [Related]
8. The rise of new psychoactive substance use in Australia.
Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
[TBL] [Abstract][Full Text] [Related]
9. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
[TBL] [Abstract][Full Text] [Related]
10. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
Zawilska JB
Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
[TBL] [Abstract][Full Text] [Related]
11. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
12. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
Heikman P; Sundström M; Pelander A; Ojanperä I
Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
[TBL] [Abstract][Full Text] [Related]
13. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
Helander A; Bäckberg M
Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
[No Abstract] [Full Text] [Related]
14. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.
Logan BK; Mohr ALA; Friscia M; Krotulski AJ; Papsun DM; Kacinko SL; Ropero-Miller JD; Huestis MA
J Anal Toxicol; 2017 Sep; 41(7):573-610. PubMed ID: 28459969
[TBL] [Abstract][Full Text] [Related]
15. Analysis of anonymized pooled urine in nine UK cities: variation in classical recreational drug, novel psychoactive substance and anabolic steroid use.
Archer JR; Hudson S; Jackson O; Yamamoto T; Lovett C; Lee HM; Rao S; Hunter L; Dargan PI; Wood DM
QJM; 2015 Dec; 108(12):929-33. PubMed ID: 25770158
[TBL] [Abstract][Full Text] [Related]
16. Novel psychoactive substances: What educators need to know.
Patterson ZR; Young MM; Vaccarino FJ
Clin Pharmacol Ther; 2017 Feb; 101(2):173-175. PubMed ID: 27756105
[TBL] [Abstract][Full Text] [Related]
17. [Intoxication with new psychoactive substances: drug unknown, but complications are still treatable].
Boersma MN; Nugteren-van Lonkhuyzen JJ; van Maarseveen EM; Kaasjager HAH; van Riel AJHP; Dekker D
Ned Tijdschr Geneeskd; 2017; 161():D1368. PubMed ID: 28659208
[TBL] [Abstract][Full Text] [Related]
18. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
[TBL] [Abstract][Full Text] [Related]
19. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J; Schaper A
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
[TBL] [Abstract][Full Text] [Related]
20. Intended and unintended use of cathinone mixtures.
Guirguis A; Corkery JM; Stair JL; Kirton SB; Zloh M; Schifano F
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
